Toho Holdings Co., Ltd. Provides Earnings Guidance for the Period Ending September 2022 and March 2023
August 05, 2022 at 12:00 am EDT
Share
Toho Holdings Co., Ltd. provides earnings guidance for the period ending September 2022 and March 2023. For the period ending September 2022, the company expects, net sales to be JPY 630,000 million, Operating profit to be JPY 5,700 million, profit attributable to owners of parent to be JPY 5,600 million or JPY 79.39 per basic share.
For the period ending March 2023, the company expects, net sales to be JPY 1,269,000 million, Operating profit to be JPY 12,300 million, profit attributable to owners of parent to be JPY 11,300 million or JPY 160.19 per basic share.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
